- Home
- CYCN vs FRSX Comparison
CYCN vs FRSX Comparison
Compare CYCN & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- FRSX
- Stock Information
- Founded
- CYCN 2018
- FRSX N/A
- Country
- CYCN United States
- FRSX Israel
- Employees
- CYCN N/A
- FRSX N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- CYCN Health Care
- FRSX Technology
- Exchange
- CYCN Nasdaq
- FRSX Nasdaq
- Market Cap
- CYCN 8.0M
- FRSX 7.0M
- IPO Year
- CYCN N/A
- FRSX 2017
- Fundamental
- Price
- CYCN $2.39
- FRSX $2.42
- Analyst Decision
- CYCN
- FRSX
- Analyst Count
- CYCN 0
- FRSX 0
- Target Price
- CYCN N/A
- FRSX N/A
- AVG Volume (30 Days)
- CYCN 22.7K
- FRSX 44.0K
- Earning Date
- CYCN 08-05-2025
- FRSX 09-21-2025
- Dividend Yield
- CYCN N/A
- FRSX N/A
- EPS Growth
- CYCN N/A
- FRSX N/A
- EPS
- CYCN N/A
- FRSX N/A
- Revenue
- CYCN $2,174,000.00
- FRSX $452,000.00
- Revenue This Year
- CYCN N/A
- FRSX N/A
- Revenue Next Year
- CYCN N/A
- FRSX N/A
- P/E Ratio
- CYCN N/A
- FRSX N/A
- Revenue Growth
- CYCN N/A
- FRSX N/A
- 52 Week Low
- CYCN $1.27
- FRSX $2.17
- 52 Week High
- CYCN $9.47
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- CYCN 43.45
- FRSX 42.63
- Support Level
- CYCN $2.36
- FRSX $2.27
- Resistance Level
- CYCN $2.59
- FRSX $2.52
- Average True Range (ATR)
- CYCN 0.22
- FRSX 0.21
- MACD
- CYCN 0.02
- FRSX 0.03
- Stochastic Oscillator
- CYCN 15.00
- FRSX 42.52
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.